Eli Lilly (LLY) Enterprise Value Growth (5y) (2014 - 2026)

Eli Lilly (LLY) Enterprise Value Growth (5y) (2014 - 2026) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn
10 Novartis Ag 108.28 Bn 107.60 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 -13.13%
Dec 31, 2025 -15.75%
Sep 30, 2025 -23.28%
Jun 30, 2025 -9.45%
Mar 31, 2025 -13.60%
Dec 31, 2024 -7.34%
Sep 30, 2024 -16.92%
Jun 30, 2024 -7.51%
Mar 31, 2024 -4.03%
Dec 31, 2023 16.55%
Sep 30, 2023 21.28%
Jun 30, 2023 16.71%
Mar 31, 2023 5.49%
Dec 31, 2022 23.49%
Sep 30, 2022 17.38%
Jun 30, 2022 13.34%
Mar 31, 2022 6.62%
Dec 31, 2021 8.95%
Sep 30, 2021 2.89%
Jun 30, 2021 4.86%